BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.185
-0.019 (-9.31%)
At close: Mar 3, 2026, 4:00 PM EST
0.185
-0.000 (-0.11%)
After-hours: Mar 3, 2026, 4:46 PM EST
BioAtla Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioAtla stock has a target of 1.00, which predicts an increase of 440.54% from the current stock price of 0.19.
Analyst Consensus: Hold
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
The average analyst rating for BioAtla stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 13, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $5 → $1 | Buy | Maintains | $5 → $1 | +440.54% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +2,602.70% | Sep 16, 2024 |
Financial Forecast
Revenue This Year
n/a
from 11.00M
Revenue Next Year
n/a
EPS This Year
-1.10
from -1.44
EPS Next Year
-0.94
from -1.10
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | n/a | n/a | ||
| Avg | n/a | n/a | ||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.13 | -0.97 | ||
| Avg | -1.10 | -0.94 | ||
| Low | -1.06 | -0.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.